Latanoprost 相關新聞

← 返回新聞總覽


Latanoprost 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Latanoprost 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Catiolanze is indicated for the reduction of elevated intraocular pressure (IOP) in adult patients with open angle glaucoma or ocular hypertension. Catiolanze is indicated for the reduction of...
  • 證據等級:L5
  • 預測適應症(20 個):
    • primary hereditary glaucoma(99.9%)
    • open-angle glaucoma(99.9%)
    • visceral calciphylaxis(99.8%)
    • hypotrichosis simplex of the scalp(99.8%)
    • venous thoracic outlet syndrome(99.8%)
    • arterial thoracic outlet syndrome(99.8%)
    • neurogenic thoracic outlet syndrome(99.7%)
    • congenital hypotrichosis milia(99.7%)
    • angiodysplasia of stomach(99.7%)
    • blue toe syndrome(99.7%)
    • lymphangiectasis(99.7%)
    • hemangioendothelioma(99.7%)
    • vascular disease(99.7%)
    • atheroembolism of kidney(99.7%)
    • idiopathic spontaneous coronary artery dissection(99.6%)
    • diffuse alopecia areata(99.6%)
    • arterial dissection-lentiginosis syndrome(99.6%)
    • alopecia(99.4%)
    • congestive heart failure(99.3%)
    • acute pulmonary heart disease(99.2%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.